Genscript USA incorporated (ambis #1749720)- mutagenesis, gene synthesis, custom plasmid preparation and reagents

Ended Purchase Order Awarded Last action

Contract number
HHSN272201501309P
Awardee
Awarding agency
Obligated
$15,029

Award facts

Opportunity
Contract value 100% obligated
$15,028.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Piscataway, NJ 08854, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$94,942
Funding Only Action P00001 -$15,029
Original award $125,000

About this award

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for $15,028.93 on September 10, 2015, for mutagenesis, gene synthesis, custom plasmid preparation, and reagents. Work is performed in Piscataway, New Jersey. The order carries a firm fixed price and no set-aside designation. Ultimate completion is September 13, 2016.

Quick answers

Who was awarded contract HHSN272201501309P?

HHSN272201501309P was awarded to Genscript USA Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2015.

How much is contract HHSN272201501309P worth?

The government has obligated $15,029 on HHSN272201501309P.

Was contract HHSN272201501309P competed?

The extent of competition for HHSN272201501309P was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award